ANIP logo

ANI Pharmaceuticals, Inc. (ANIP) Cash From Investing

Annual CFI:

-$404.72M-$386.21M(-2086.37%)
December 31, 2024

Summary

  • As of today, ANIP annual cash from investing is -$404.72 million, with the most recent change of -$386.21 million (-2086.37%) on December 31, 2024.
  • During the last 3 years, ANIP annual cash from investing has fallen by -$299.24 million (-283.68%).
  • ANIP annual cash from investing is now -2096.94% below its all-time high of $20.27 million, reached on December 31, 2013.

Performance

ANIP Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPcash flow metrics

Quarterly CFI:

-$6.16M+$746.00K(+10.80%)
September 30, 2025

Summary

  • As of today, ANIP quarterly cash from investing is -$6.16 million, with the most recent change of +$746.00 thousand (+10.80%) on September 30, 2025.
  • Over the past year, ANIP quarterly cash from investing has increased by +$392.36 million (+98.45%).
  • ANIP quarterly cash from investing is now -131.88% below its all-time high of $19.33 million, reached on June 30, 2013.

Performance

ANIP Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPcash flow metrics

TTM CFI:

-$43.60M+$392.36M(+90.00%)
September 30, 2025

Summary

  • As of today, ANIP TTM cash from investing is -$43.60 million, with the most recent change of +$392.36 million (+90.00%) on September 30, 2025.
  • Over the past year, ANIP TTM cash from investing has increased by +$355.22 million (+89.07%).
  • ANIP TTM cash from investing is now -315.12% below its all-time high of $20.27 million, reached on December 31, 2013.

Performance

ANIP TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ANIP Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-2086.4%+98.5%+89.1%
3Y3 Years-283.7%+37.2%+54.0%
5Y5 Years-1369.1%-6.1%+35.5%

ANIP Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-2471.6%at low-169.0%+98.5%-799.3%+90.0%
5Y5-Year-2471.6%at low-169.0%+98.5%-799.3%+90.0%
All-TimeAll-Time-2096.9%at low-131.9%+98.5%-315.1%+90.0%

ANIP Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$6.16M(+10.8%)
-$43.60M(+90.0%)
Jun 2025
-
-$6.91M(+65.2%)
-$435.96M(-0.6%)
Mar 2025
-
-$19.85M(-85.8%)
-$433.50M(-7.1%)
Dec 2024
-$404.72M(-2086.4%)
-$10.68M(+97.3%)
-$404.72M(-1.5%)
Sep 2024
-
-$398.52M(-8857.6%)
-$398.82M(-8126.4%)
Jun 2024
-
-$4.45M(-149.8%)
-$4.85M(+32.9%)
Mar 2024
-
$8.93M(+286.9%)
-$7.22M(+61.0%)
Dec 2023
-$18.51M(-17.6%)
-$4.78M(-5.0%)
-$18.51M(-9.7%)
Sep 2023
-
-$4.55M(+33.3%)
-$16.87M(+23.8%)
Jun 2023
-
-$6.83M(-190.1%)
-$22.14M(-39.1%)
Mar 2023
-
-$2.35M(+25.1%)
-$15.91M(-1.1%)
Dec 2022
-$15.74M(+85.1%)
-$3.14M(+68.0%)
-$15.74M(+83.4%)
Sep 2022
-
-$9.81M(-1524.8%)
-$94.81M(-10.8%)
Jun 2022
-
-$604.00K(+72.3%)
-$85.58M(+20.0%)
Mar 2022
-
-$2.18M(+97.4%)
-$106.92M(-1.4%)
Dec 2021
-$105.48M(-54.4%)
-$82.21M(>-9900.0%)
-$105.48M(-315.5%)
Sep 2021
-
-$583.00K(+97.3%)
-$25.39M(+17.1%)
Jun 2021
-
-$21.95M(-2878.3%)
-$30.61M(-165.9%)
Mar 2021
-
-$737.00K(+65.2%)
-$11.51M(+83.1%)
Dec 2020
-$68.32M(-148.0%)
-$2.12M(+63.5%)
-$68.32M(-1.1%)
Sep 2020
-
-$5.81M(-104.0%)
-$67.58M(-6.1%)
Jun 2020
-
-$2.85M(+95.1%)
-$63.70M(+1.7%)
Mar 2020
-
-$57.55M(-4088.2%)
-$64.81M(-135.3%)
Dec 2019
-$27.55M(-0.6%)
-$1.37M(+28.9%)
-$27.55M(-3.6%)
Sep 2019
-
-$1.93M(+51.2%)
-$26.58M(+38.3%)
Jun 2019
-
-$3.96M(+80.5%)
-$43.09M(+5.1%)
Mar 2019
-
-$20.29M(-4884.0%)
-$45.39M(-65.8%)
Dec 2018
-$27.38M(+74.6%)
-$407.00K(+97.8%)
-$27.38M(+64.5%)
Sep 2018
-
-$18.44M(-194.8%)
-$77.09M(-26.1%)
Jun 2018
-
-$6.25M(-174.6%)
-$61.13M(-6.9%)
Mar 2018
-
-$2.28M(+95.5%)
-$57.18M(+47.1%)
Dec 2017
-$107.99M(+27.6%)
-$50.12M(-1920.8%)
-$107.99M(-82.2%)
Sep 2017
-
-$2.48M(-7.6%)
-$59.27M(-2.4%)
Jun 2017
-
-$2.30M(+95.7%)
-$57.88M(+52.4%)
Mar 2017
-
-$53.09M(-3719.7%)
-$121.61M(+21.1%)
Dec 2016
-$149.06M(-356.1%)
-$1.39M(-27.6%)
-$154.06M(-0.2%)
Sep 2016
-
-$1.09M(+98.4%)
-$153.78M(+14.3%)
Jun 2016
-
-$66.03M(+22.8%)
-$179.46M(-57.9%)
Mar 2016
-
-$85.55M(-7642.2%)
-$113.62M(-247.6%)
Dec 2015
-$32.68M(+8.6%)
-$1.10M(+95.9%)
-$32.68M(-2.4%)
Sep 2015
-
-$26.77M(>-9900.0%)
-$31.92M(-15.3%)
Jun 2015
-
-$198.00K(+95.7%)
-$27.68M(+0.2%)
Mar 2015
-
-$4.61M(-1264.5%)
-$27.73M(+22.4%)
Dec 2014
-$35.75M(-276.4%)
-$338.00K(+98.5%)
-$35.75M(-7.7%)
Sep 2014
-
-$22.53M(-8804.3%)
-$33.19M(-210.4%)
Jun 2014
-
-$253.00K(+98.0%)
-$10.69M(-220.2%)
Mar 2014
-
-$12.63M(-666.3%)
$8.89M(-56.1%)
Dec 2013
$20.27M(+3373.6%)
$2.23M(+6720.2%)
$20.27M(+12.9%)
Sep 2013
-
-$33.70K(-100.2%)
$17.95M(+2.5%)
Jun 2013
-
$19.33M(+1634.0%)
$17.52M(+1064.3%)
Mar 2013
-
-$1.26M(-1427.4%)
-$1.82M(-193.5%)
Dec 2012
-$619.10K
-$82.50K(+82.3%)
-$619.20K(-1.3%)
Sep 2012
-
-$465.40K(-5014.3%)
-$611.00K(-146.1%)
DateAnnualQuarterlyTTM
Jun 2012
-
-$9100.00(+85.4%)
-$248.30K(+55.7%)
Mar 2012
-
-$62.20K(+16.3%)
-$560.90K(+22.1%)
Dec 2011
-$719.90K(-1091.9%)
-$74.30K(+27.7%)
-$719.90K(-6.0%)
Sep 2011
-
-$102.70K(+68.1%)
-$679.30K(-17.2%)
Jun 2011
-
-$321.70K(-45.4%)
-$579.50K(-111.7%)
Mar 2011
-
-$221.20K(-556.4%)
-$273.80K(-353.3%)
Dec 2010
-$60.40K(-102.1%)
-$33.70K(-1062.1%)
-$60.40K(-54.9%)
Sep 2010
-
-$2900.00(+81.9%)
-$39.00K(-6.0%)
Jun 2010
-
-$16.00K(-105.1%)
-$36.80K(-76.9%)
Mar 2010
-
-$7800.00(+36.6%)
-$20.80K(-100.7%)
Dec 2009
$2.86M(-74.7%)
-$12.30K(-1657.1%)
$2.86M(-75.0%)
Sep 2009
-
-$700.00(>-9900.0%)
$11.45M(-7.8%)
Jun 2009
-
$0.00(-100.0%)
$12.41M(-13.1%)
Mar 2009
-
$2.87M(-66.5%)
$14.28M(+26.1%)
Dec 2008
$11.33M(+200.8%)
$8.58M(+791.0%)
$11.33M(+236.1%)
Sep 2008
-
$962.80K(-48.5%)
-$8.32M(+10.8%)
Jun 2008
-
$1.87M(+2361.1%)
-$9.34M(+17.1%)
Mar 2008
-
-$82.70K(+99.3%)
-$11.26M(-0.2%)
Dec 2007
-$11.24M(-326.8%)
-$11.07M(>-9900.0%)
-$11.24M(-289.1%)
Sep 2007
-
-$49.90K(+7.2%)
$5.94M(+1296.7%)
Jun 2007
-
-$53.80K(+11.8%)
$425.50K(-86.2%)
Mar 2007
-
-$61.00K(-101.0%)
$3.09M(-37.7%)
Dec 2006
$4.96M(-31.6%)
$6.11M(+209.7%)
$4.96M(+6025.7%)
Sep 2006
-
-$5.57M(-313.3%)
$80.90K(-98.9%)
Jun 2006
-
$2.61M(+44.5%)
$7.29M(-4.9%)
Mar 2006
-
$1.81M(+46.5%)
$7.67M(+5.9%)
Dec 2005
$7.24M(+144.7%)
$1.23M(-25.1%)
$7.24M(+171.5%)
Sep 2005
-
$1.65M(-44.9%)
-$10.12M(+14.1%)
Jun 2005
-
$2.98M(+116.6%)
-$11.78M(+20.4%)
Mar 2005
-
$1.38M(+108.5%)
-$14.79M(+8.7%)
Dec 2004
-$16.20M(>-9900.0%)
-$16.13M(>-9900.0%)
-$16.20M(>-9900.0%)
Sep 2004
-
-$9800.00(+69.3%)
-$76.30K(-7.3%)
Jun 2004
-
-$31.90K(-5.3%)
-$71.10K(-81.4%)
Mar 2004
-
-$30.30K(-604.7%)
-$39.20K(-340.4%)
Dec 2003
-$8900.00(+77.2%)
-$4300.00(+6.5%)
-$8900.00(-1.1%)
Sep 2003
-
-$4600.00(>-9900.0%)
-$8800.00(+33.3%)
Jun 2003
-
$0.00(0.0%)
-$13.20K(+41.1%)
Mar 2003
-
$0.00(+100.0%)
-$22.40K(+42.6%)
Dec 2002
-$39.00K(+55.0%)
-$4200.00(+53.3%)
-$39.00K(+13.7%)
Sep 2002
-
-$9000.00(+2.2%)
-$45.20K(+49.8%)
Jun 2002
-
-$9200.00(+44.6%)
-$90.00K(+11.1%)
Mar 2002
-
-$16.60K(-59.6%)
-$101.20K(-16.7%)
Dec 2001
-$86.70K(-100.7%)
-$10.40K(+80.7%)
-$86.70K(+1.5%)
Sep 2001
-
-$53.80K(-163.7%)
-$88.00K(-129.2%)
Jun 2001
-
-$20.40K(-871.4%)
-$38.40K(-12.9%)
Mar 2001
-
-$2100.00(+82.1%)
-$34.00K(+21.3%)
Dec 2000
-$43.20K(-928.6%)
-$11.70K(-178.6%)
-$43.20K(-37.1%)
Sep 2000
-
-$4200.00(+73.8%)
-$31.50K(-15.4%)
Jun 2000
-
-$16.00K(-41.6%)
-$27.30K(-141.6%)
Mar 2000
-
-$11.30K(>-9900.0%)
-$11.30K(>-9900.0%)
Dec 1999
-$4200.00(+96.6%)
-
-
Dec 1999
-
$0.00
$0.00
Dec 1998
-$125.00K
-
-

FAQ

  • What is ANI Pharmaceuticals, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for ANI Pharmaceuticals, Inc.?
  • What is ANI Pharmaceuticals, Inc. annual cash from investing year-on-year change?
  • What is ANI Pharmaceuticals, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for ANI Pharmaceuticals, Inc.?
  • What is ANI Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?
  • What is ANI Pharmaceuticals, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for ANI Pharmaceuticals, Inc.?
  • What is ANI Pharmaceuticals, Inc. TTM cash from investing year-on-year change?

What is ANI Pharmaceuticals, Inc. annual cash from investing?

The current annual cash from investing of ANIP is -$404.72M

What is the all-time high annual cash from investing for ANI Pharmaceuticals, Inc.?

ANI Pharmaceuticals, Inc. all-time high annual cash from investing is $20.27M

What is ANI Pharmaceuticals, Inc. annual cash from investing year-on-year change?

Over the past year, ANIP annual cash from investing has changed by -$386.21M (-2086.37%)

What is ANI Pharmaceuticals, Inc. quarterly cash from investing?

The current quarterly cash from investing of ANIP is -$6.16M

What is the all-time high quarterly cash from investing for ANI Pharmaceuticals, Inc.?

ANI Pharmaceuticals, Inc. all-time high quarterly cash from investing is $19.33M

What is ANI Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?

Over the past year, ANIP quarterly cash from investing has changed by +$392.36M (+98.45%)

What is ANI Pharmaceuticals, Inc. TTM cash from investing?

The current TTM cash from investing of ANIP is -$43.60M

What is the all-time high TTM cash from investing for ANI Pharmaceuticals, Inc.?

ANI Pharmaceuticals, Inc. all-time high TTM cash from investing is $20.27M

What is ANI Pharmaceuticals, Inc. TTM cash from investing year-on-year change?

Over the past year, ANIP TTM cash from investing has changed by +$355.22M (+89.07%)
On this page